The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...

(CN) - A Minnesota woman can sue generic drug makers for allegedly failing to warn her that long-term use of the generic version of Reglan could lead to a severe movement disorder, the 8th Circuit ...

(CN) - A woman who claims she was harmed by a generic form of Reglan can sue the manufacturer of the name-brand acid-reflux drug, but not the producers of generic versions, a California appeals court ...

In dismissing claims against manufacturers of generic and over-the-counter versions of heartburn medicine Zantac, a U.S. District court judge in Florida has upheld the preemption argument, a ...

On Jan. 20, 2015, the U.S. Supreme Court declined to hear an appeal involving failure-to-warn claims against generic pharmaceutical manufacturers. Teva Pharms. USA Inc. v. Super. Ct., No. 13-956 (U.S.

The motion comes as class action attorneys are grappling with the advent of third parties that, through the use of technology, have advertised their services to assist potential class members in ...